Relation of body mass index to cancer risk in 362,552 Swedish men

Cancer Causes and Control

Volumn 17, Issue 7, 2006, Pages 901-909

  Samanic, Claudine ^a   Chow, Wong Ho ^a   Gridley, Gloria ^a   Jarvholm, Bengt ^b   Fraumeni Jr , Joseph F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Body mass index; Cancer incidence; Obesity; Sweden

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CARCINOGENESIS; COLON CANCER; COLON CARCINOGENESIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONNECTIVE TISSUE TUMOR; CONTROLLED STUDY; DEATH; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FOLLOW UP; GROUPS BY AGE; HUMAN; KIDNEY CARCINOMA; LIVER CANCER; LIVER CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; OBESITY; PANCREAS CANCER; PHYSICAL EXAMINATION; POISSON DISTRIBUTION; PRIORITY JOURNAL; RECTUM CANCER; RISK ASSESSMENT; RISK FACTOR; SKIN CARCINOGENESIS; SMOKING; STATISTICAL ANALYSIS; STATISTICAL MODEL; SWEDEN; WEIGHT GAIN;

ADULT; BODY MASS INDEX; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OBESITY; RISK FACTORS; SWEDEN; WAIST-HIP RATIO; WEIGHT GAIN;

EID: 33746089143     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-006-0023-9     Document Type: Article

References (96)

1. IARC handbooks of cancer prevention (2002) Weight control and physical activity, vol 6. International Agency for Research on Cancer, Lyon, France
2. Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity and cancer risk. Lancet Oncol 3:565-574
3. Wolk A, Gridley G, Svensson M, et al (2001) A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 12:13-21
4. Moller H, Mellemgaard A, Lindvig K, Olsen JH (1994) Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 30A:344-350
5. Calle E, Rodriguez C, Walker-Thurmond K, Thun MJ. (2003) Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348:1625-1638
6. Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, Fraumeni JF Jr. (2004) Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 15:35-44
7. Bird CL, Frankl HD, Lee ER, Haile RW (1998) Obesity, weight gain, large weight changes, and adenomatous polyps of the left colon and rectum. Am J Epidemiol 147:670-680
8. Isaksson B, Jonsson F, Pedersen NL, Larsson J, Feychting, Permert J (2002) Lifestyle factors and pancreatic risk: a cohort study. Int J Cancer 98:480-482
9. Lindblad P, Wolk A, Bergstrom R, Persson I, Adami HO (1994) The role of obesity and weight fluctuations in the etiology of renal cell cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 3:631-639
10. Ballard-Barbash R, Schatzkin A, Taylor PR, Kahle LL (1990) Association of change in body mass with breast cancer. Cancer Res 50:2152-2155
11. Mattsson B, Rutqvist LE, Wallgren A (1985) Undernotification of diagnosed cancer cases to the Stockhom Cancer Registry. Int J Epidemiol 14:64-69
12. Report of a WHO consultation. Obesity: preventing, managing the global epidemic. 894:i-xii, 1-253. 2000. World Health Organization. World Health Organ Tech Rep Ser
13. Chow WH, Gridley G, Fraumeni JF Jr, Jarvholm B (2000) Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 343:1305-1311
14. Preston DL, Lubin JH, Pierce DA, McConney ME (1996) Epicure User's Guide. HiroSoft International Corporation, Seattle, WA
15. Breslow NE, Day NE (1987) The design and analysis of cohort studies. In: International Agency for Research on Cancer, ed. In: Statistical methods in cancer research. Lyon
16. Chow W., Blot W., Vaughan TL, et al (1998) Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 90:150-155
17. Wu AH, Wan P, Bernstein L (2001) A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus. Cancer Causes Control 12:721-732
18. Lagergren J, Bergstrom R, Nyren O (1999) Association between body mass index and adenocarcinoma of the esophagus and gastric cardia. Arch Intern Med 130:883-890
19. Brown LM, Swanson CA, Gridley G, et al (1995) Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 87:104-109
20. Lindblad M, Garcia A, Lagergren J (2005) Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nest case-control study. Cancer Causes Control 16:285-294
21. Engeland A, Tretli S, Bjorge T (2004) Height and body mass index in relation to esophageal cancer; 23-year follow-up of two million Norwegian mean and women. Cancer Causes Control 15:837-843
22. Lagergren J (2005) Adenocarcinoma of the esophagus: what exactly is the size of the problem and who is at risk? Gut 54(Suppl I):i1-i5
23. Brown LM, Hoover RN, Greenberg RS, et al (1994) Are racial differences in squamous cell esophageal cancer explained by alcohol and tobacco use? J Natl Cancer Inst 86:1340-1345
24. Brown LM, Hoover RN, Silverman D, et al (2001) Excess incidence of squamous cell esophageal cancer among US black men: role of social class and other risk factors. Am J Epidemiol 153:114-122
25. Vaughan TL, Davis S, Kristal A, Thomas DB (1995) Obesity, alcohol and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidem Biomarkers Prev 4:85-92
26. Pan SY, Johnson KC, Ugnat AM, Wen SW, Mao Y, Canadian Cancer Registries Epidemiology Research Group (2004) Association of obesity and cancer risk in Canada. Am J Epidemiol 159:259-268
27. Russo A, Franceschi S, La Vecchia C, et al (1998) Body size and colorectal-cancer risk. Int J Cancer 78:161-165
28. Ford ES (1999) Body mass index and colon cancer in a national sample of adult US men and women. Am J Epidemiol 150:390-398
29. Gerhardsson De Verdier M, Hagman U, Steineck G, Rieger A, Norell SE (1990) Diet, body mass and colorectal cancer: a case-referent study in Stockholm. Int J Cancer 46:832-838
30. Kreger BE, Anderson KM, Shatzkin A, Splansky GL (1992) Serum cholesterol level, body mass index, and the risk of colon cancer. Cancer 70:1038-1043
31. Honjo S, Kono S, Shinchi K, et al (1995) The relation of smoking, alcohol use and obesity to risk of sigmoid colon and rectal adenomas. Jpn J Cancer Res 86:1019-1026
32. Le Marchand L, Wilkens LR, Mi MP (1992) Obesity in youth and middle age and risk of colorectal cancer in men. Cancer Causes Control 3:349-354
33. Graham S, Marshall J, Haughey B, et al (1988) Dietary epidemiology of cancer of the colon in western New York. Am J Epidemiol 128:490-503
34. Slattery ML, Caan BJ, Benson J, Murtaugh M (2003) Energy balance and rectal cancer: an evaluation of energy intake, energy expenditure, and body mass index. Nutr Cancer 166-171
35. Mao Y, Pan S, Wen SW, Johnson KC, Canadian Cancer Registries Epidemiology Research Group (2003) Physical inactivity, energy intake, obesity and the risk of rectal cancer in Canada. Int J Cancer 105:831-837
36. Giacosa A, Franceschi S, La Vecchia C, Favero A, Andreatta R (1999) Energy intake, overweight, physical exercise and colorectal cancer risk. Eur J Cancer Prev 8:S53-S60
37. Kono S, Handa K, Hayabuchi H, et al (1999) Obesity, weight gain and risk of colon adenomas in Japanese men. Jpn J Cancer Res 90:805-811
38. Bird CL, Frankl HD, Lee ER, Haile RW (1998) Obesity, weight gain, large weight changes, and adenomatous polyps of the left colon and rectum. Am J Epidemiol 147:670-680
39. Whittemore AS, Paffenbarger RS, Anderson K, Lee JE (1985) Early precursors of site-specific cancers in college men and women. J Natl Cancer Inst 74:43-51
40. Shapiro JA, Williams MA, Weiss NS (1999) Body mass index and risk of renal cell carcinoma. Epidemiology 10:188-191
41. Moore LE, Wilson RT, Campleman SL (2005) Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review. Cancer Invest 23:240-255
42. Bjorge T, Tretli S, Engeland A (2004) Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol 160:1168-1176
43. Presti JC Jr (2005) Obesity and prostate cancer. Curr Opin Urol 15:13-16
44. Nomura AM (2001) Body size and prostate cancer risk. Epidemiol Rev 126-131
45. Engeland A, Tretli S, Bjorge T (2003) Height, body mass index, and prostate cancer: a follow-up of 950,000 Norwegian men. Br J Cancer 89:1237-1242
46. Andersson SO, Wolk A, Bergstrom R, et al (1997) Body size and prostate cancer: a 20-year follow-up study among 135,006 Swedish construction workers. J Natl Cancer Inst 89:385-389
47. Amling CL (2005) Relationship between obesity and prostate cancer. Curr Opin Urol 15:167-171
48. Giovanucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC (1997) Height, body weight and risk of prostate cancer. Cancer Epidem Biomarkers Prev 6:557-563
49. Freedland SJ, Giovannucci E, Platz EA (2006) Are findings from studies of obesity and prostate cancer really in conflict? Cancer Causes Control 17:5-9
50. Larsson SC, Permert J, Hakansson N, Naslund I, Bergkvist L, Wolk A (2005) Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Br J Cancer 93:1310-1315
51. Silverman DT, Swanson CA, Gloria G, et al (1998) Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst 90:1710-1719
52. Patel AV, Rodriguez C, Bernstein L, Chao A, Thun MJ, Calle EE (2005) Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort. Cancer Epidemiol Biomarkers Prev 14:459-466
53. Michaud DS, Giovanucci E, Willett WC, Colditz GA, Stampfer MJ, Fuchs CS (2001) Physical activity, obesity, height, and risk or pancreatic cancer. JAMA 286:921-929
54. Lee IM, Sesso HD, Oguma Y, Paffenbarger RS (2003) Physical activity, body weight, and pancreatic cancer mortality. Br J Cancer 88:679-683
55. Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D (2005) A prospective study of medical conditions, anthropometry, physical activity, and pancreatic cancer in male smokers (Finland). Cancer Causes Control 13:417-426
56. Howe GR, Jain M, Miller AB (1990) Dietary factors and risk of pancreatic cancer: results of a Canadian population-based case-control study. Int J Cancer 45:604-608
57. Friedman GD, Van Den Eeden SK (1993) Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol 22:30-37
58. Berrington de Gonzalez A, Sweetland S, Spencer E (2003) A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer 89:519-523
59. Qian Y, Fan JG (2005) Obesity, fatty liver and liver cancer. Hepatobiliary Pancreat Dis Int 4:173-177
60. Cladwell SH, Crespo DM, Kang HS, As-Osaimi AMS (2004) Obesity and hepatocellular carcinoma. Gastroenterology 127:S97-S103
61. Yang SQ, Lin HZ, Hwang J, Chacko VP, Diehl AM (2001) Hepatic hyperplasia and noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition. Cancer Res 61:5016-5023
62. Angelico F, Del Ben M, Conti R, et al (2003) Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases. J Gastroenterol Hepatol 18:588-594
63. Pagano G, Pacini G, Gambino R, et al (2002) Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 35:367-372
64. Gallus S, Naldi L, Martin L, Martinelli M, Carlo La Vecchia on behalf of the Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology (GISED) (2006) Anthropometric measures and risk of cutaneous malignant melanoma: a case-control study from Italy. Melanoma Res 16:83-87
65. Kirkpatrick CS, White E, Lee JA (1994) Case-control study of malignant melanoma in Washington State. II. Diet, alcohol, and obesity. Am J Epidemiol 139:869-880
66. Holman CD, Armstrong BK, Heenan PJ (1984) Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer 50:673-680
67. Le MG, Cabanes PA, Desvignes V, Chanteau MF, Mlika N, Avril MF (1992) Oral contraceptive use and risk of cutaneous malignant melanoma in a case-control study of French women. Cancer Causes Control 3:199-205
68. Gallagher RP, Elwood JM, Hill GB, Coldman AJ, Threlfall WJ, Spinelli JJ (1985) Reproductive factors, oral contraceptives and risk of malignant melanoma in women: Western Canada Melanoma study. Br J Cancer 52:901-907
69. Osterlind A, Tucker MA, Stone BJ, Jensen OM (1988) The Danish case-control study of cutaneous malignant melanoma. Int J Cancer 42:821-824
70. Shors AR, Solomon C, McTiernan A, White E (2001) Melanoma risk in relation to height, weight and exercise (United States). Cancer Causes Control 12:599-606
71. Thune I, Olsen A, Albrektsen G, Tretli S (1993) Cutaneous malignant melanoma: association with height, weight and body-surface area. A prospective study in Norway. Int J Cancer 55:555-561
72. Millen AE, Tucker MA, Hartge P, et al (2004) Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev 13:1042-1051
73. Osterlind A, Tucker MA, Stone BJ, Jensen OM (1988) The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women. Int J Cancer 42:821-824
74. Veierod MB, Thelle DS, Laake P (1997) Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women. Int J Cancer 71:600-604
75. Snell RS, Bischitz PG (1960) The effect of large doses of estrogen and progesterone on melanin pigmentation. J Invest Dermatol 35:75-82
76. Armstrong BK, Englund A (1996) Cutaneous malignant melanoma. In: Schottenfield D, Fraumeni JF Jr. (eds) New York, NY: Oxford University Press, pp 1282-1312
77. Beral V, Evans S, Shaw H (1984) Oral contraceptive use and malignant melanoma in Australia. Br J Cancer 50:681-685
78. Feskanich D, Hunter DJ, Willett WC, et al (1999) Oral contraceptive use and risk of melanoma in premenopausal women. Br J Cancer 81:918-923
79. Holly EA, Cress RD, Ahn DK (1995) Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use. Am J Epidemiol 141:943-950
80. Karagas MR, Stukel TA, Dykes J, et al (2002) A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use. Br J Cancer 86:1085-1092
81. Tavani S, Soler M, La Vecchia C, Negri E, Gallus S, Franceschi S (1999) Body weight and risk of soft-tissue sarcoma. Br J Cancer 81:890-892
82. Cerhan JR, Janney CA, Vachon CM, et al (2002) Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study. Am J Epidemiol 156:527-535
83. Holly EA, Lele C, Bracci PM, McGrath MS (1999) Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol 150:375-389
84. Estey E, Thall P, Kantarjian H, Pierce S, Kornblau S, Keating M (1997) Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia. Leukemia 11:1661-1664
85. Sobal J, Stunkard AJ (1989) Socioeconomic status and obesity: a review of the literature. Psychol Bull 105:260-275
86. Oliveria SA, Christos PJ (1997) The epidemiology of physical activity and cancer. Ann NY Acad Sci 29:79-90
87. Tymchuk CN, Tessler SB, Aronson WJ, Barnard WJ (1998) Effects of diet and exercise on insulin, sex-hormone binding globulin, and prostate-specific antigen. Nutr Cancer 31:127-131
88. Key TJ, Allen NE, Spencer EA, Travis RC (2002) The effect of diet on risk of cancer. Lancet 360:861-888
89. La Vecchia C (1994) Dietary fat, obesity and cancer. In: Hill M, Giacosa A, Caygill C (eds) Epidemiology of diet and cancer. Ellis Horwood Limited, New York, pp 277-291
90. Molarius A, Seidell JC, Kuulasmaa K, Dobson AJ, Sans S (1997) Smoking and relative body weight: an international perspective from the WHO MONICA project. J Epidemiol Community Health 51:252-560
91. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Rev 4:579-591
92. Giovanucci E (1999) Insulin-like growth factor-1 and binding protein-3 and risk of cancer. Horm Res 51:34-41
93. Kahn BB, Flier JS (2000) Obesity and insulin resistance. J Clin Invest 106:473-481
94. Marchav S (1998) The haematopoietic effects of growth hormone and insulin-like growth factor-I. J Ped Endocrinol Metab 11:677-685
95. Cottam DR, Mattar SG, Barinas-Mitchell E, et al (2004) The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obesity Surgery 14:589-600
96. Shacter E, Weitzman SA (2002) Chronic inflammation and cancer. Oncology 16:217-229